Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TNFRSF10B antibody (Extracellular Domain)

The Mouse Monoclonal anti-TNFRSF10B antibody (Clone DR5-01-1) (ABIN238401) specifically detects TNFRSF10B in FACS. The antibody is reactive with Human samples.
Catalog No. ABIN238401
$444.00
Plus shipping costs $50.00
0.1 mg
Shipping to: United States
Delivery in 1 to 2 Business Days

Quick Overview for TNFRSF10B antibody (Extracellular Domain) (ABIN238401)

Target

See all TNFRSF10B Antibodies
TNFRSF10B (Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B))

Reactivity

  • 165
  • 23
  • 7
  • 1
  • 1
Human

Host

  • 94
  • 61
  • 19
  • 2
  • 1
  • 1
Mouse

Clonality

  • 97
  • 78
  • 2
Monoclonal

Conjugate

  • 98
  • 14
  • 11
  • 6
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This TNFRSF10B antibody is un-conjugated

Application

  • 97
  • 47
  • 44
  • 38
  • 21
  • 18
  • 16
  • 14
  • 14
  • 13
  • 10
  • 8
  • 5
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

DR5-01-1
  • Binding Specificity

    • 15
    • 14
    • 11
    • 6
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Extracellular Domain

    Specificity

    The antibody DR5-01-1 recognizes an extracellular domain of TRAIL-R2 (DR5). TRAIL-R2 is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L).

    Cross-Reactivity (Details)

    Species reactivity (tested):Human.

    Characteristics

    Synonyms: TNFRSF10B, DR5, KILLER, TRICK2, ZTNFR9, Death receptor 5, TRAIL receptor 2, TRAIL-R2,Tumor necrosis factor receptor superfamily member 10B, TNF-related apoptosis-inducingligand receptor 2

    Purification

    Protein-A Affinity Chromatography.

    Immunogen

    Recombinant fusion protein of human IgG heavy chain and extracellular domain of DR5.

    Isotype

    IgG1
  • Application Notes

    Flow Cytometry: 1-10 μg/mLPositive control: JURKAT human peripheral blood leukemia T cell line.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    PBS, pH 7.4 with 15 mM Sodium Azide as preservative.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C/-20 °C

    Storage Comment

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
    Shelf life: one year from despatch.

    Expiry Date

    12 months
  • Target

    TNFRSF10B (Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B))

    Alternative Name

    CD262 / TRAILR2

    Background

    TRAIL-R2 (CD262, DR5) is one of two TNF superfamily member intracellular death domain containing receptors for TRAIL (APO2L). Apoptosis, or programmed cell death, occurs during normal cellular differentiation and development of multicellular organisms. Apoptosis is induced by certain cytokines including tumor necrosis factor (TNF) and Fas ligand in the TNF family through their death domain containing receptors, TNF receptor 1 (TNFR1) and Fas, respectively. Another member in the TNF family has been identified and designated TRAIL (for TNF related apoptosis inducing ligand) and Apo2L (for Apo2 ligand). Receptors for TRAIL include two death domain containing receptors, DR4 and DR5, as well as two decoy receptors, DcR1 and DcR2, lacking the intracellular signaling death domain. DcR1 (also called TRID), like the related death receptors DR4 and DR5, contains two extracellular cysteine rich domains. However, DcR1 contains no intracellular death domain and is thus incapable of signaling apoptosis. It has been suggested DcR1 is responsible for TRAIL resistance in normal human tissues including heart, placenta, lung, liver, kidney, spleen, and bone marrow. DR5 is a member of the TNF receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor related apoptosis inducing ligand (TNFSF10/TRAIL/APO2L), and transduces apoptosis signal. Studies with FADD deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein.Synonyms: DR5, Death receptor 5, KILLER, TNF-related apoptosis-inducing ligand receptor 2, TNFRSF10B, TRAIL receptor 2, TRAIL-R2, TRICK2, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9

    Gene ID

    8795

    UniProt

    O14763

    Pathways

    p53 Signaling, Apoptosis, Positive Regulation of Endopeptidase Activity
You are here:
Chat with us!